Oral Azacitidine Benefits Some Older Adults With AML

TUESDAY, Dec. 29, 2020 -- For older patients with acute myeloid leukemia (AML) who are in remission after chemotherapy, those receiving maintenance therapy with the oral formulation of azacitidine (CC-486) versus placebo had longer overall and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news